BMS (n=18) | MSG (n=19) | p value | |
Death (total) | 0 (0%) | 0 (0%) | 1.00 |
Hierarchical MACE at 6 months | 2 (11.1%) | 1 (5.3%) | 0.52 |
Clinically driven TLR | 1 (5.6%) | 1 (5.3%) | 0.74 |
Clinically driven TVR | 1 (5.6%) | 0 (0%) | 0.49 |
Target lesion-related MI | 0 (0%) | 1 (5.3%) | 0.32 |
Stent thrombosis | 0 (0%) | 0 (0%) | 1.00 |
BMS, bare metal stent; MACE, major adverse cardiac event; MI, myocardial infarction; MSG, microengineered stent grooves; TLR, target lesion revascularisation; TVR, target vessel revascularisation.